Article

Diagnostic techniques for the glaucoma patient with OSD

Accurate diagnosis of ocular surface disease (OSD) is essential in patients with glaucoma who complain of burning, itching, foreign body sensation, or a dry, gritty sensation often in concert with paradoxical tearing.

Accurate diagnosis of ocular surface disease (OSD) is essential in patients with glaucoma who complain of burning, itching, foreign body sensation, or a dry, gritty sensation often in concert with paradoxical tearing.

Table 1 on Page 28 illustrates common signs of OSD. Once a firm diagnosis of OSD has been achieved, only then can eye-care practitioners begin to address the issue and effectively treat their patients.

As summarized in Table 2 many useful diagnostic tests are available to the eye-care practitioner. In my opinion, the single most useful diagnostic test available is lissamine green staining. Lissamine green is available in strips or liquid, does not sting the patient's eyes when applied, and can provide a diagnosis of OSD in seconds whereby punctuate corneal epithelial changes are noted.

The Schirmer tear test is a rapid, simple evaluation of tear production. Although the Schirmer tear test has fallen out of favor due to difficulty in interpreting results, this test remains a useful source of information that should be included in every patient's work-up.

Direct visualization of the ocular surface, lid margins, conjunctiva, etc., can be achieved easily by slit lamp examination. In fact, conjunctival inflammation can be readily observed by direct observation of the bulbar conjunctiva.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.